Hillhouse, CITIC PE Participate In $75M Round For BeiGene
November 17, 2014 — 16:49 CST
This Data Is Locked!
This area is available only to Subscribers.
Beijing-based Chinese oncology research and development firm BeiGene (Beijing), Co., Ltd. has completed a new round of financing worth RMB450 million (US$75 million), according to... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
